ArticleDermatology and therapy2026

Short-Term Effectiveness and Safety of Deucravacitinib in Psoriasis: A Multicenter Real-World Study with Scalp-Specific Outcomes-IL PSO (Italian Landscape Psoriasis).

Luciano Ibba et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.